RT Journal
A1 Green JB, Ross JS, Jackevicius CA, Shah ND, Krumholz HM
T1 When choosing statin therapy: The case for generics
JF JAMA Internal Medicine
JO JAMA Internal Medicine
YR 2013
FD February 11
VO 173
IS 3
SP 229
OP 232
DO 10.1001/jamainternmed.2013.1529
UL http://dx.doi.org/10.1001/jamainternmed.2013.1529
AB The development of “Top 5” lists across specialties and at regular intervals can help to remind physicians that optimal care is often possible at a lower cost. For purposes of cardiovascular risk reduction, generic statins, or their brand equivalents if priced similarly, remain the appropriate choice for dyslipidemic patients initiating statin therapy. In this article, we review the evidence supporting the choice of generic statins.